EZZ Life Science’s Director Qizhou Qin Increases Shareholding

EZZ Life Science Holdings Ltd. (AU:EZZ) has released an update.

Pick the best stocks and maximize your portfolio:

EZZ Life Science Holdings Ltd. has reported a change in the securities interests of director Qizhou Qin, with the acquisition of 90,830 fully paid ordinary shares through an on-market trade. The transaction, carried out between December 9 and 11, 2024, was priced between $2.52 and $2.71 per share. This adjustment reflects Qin’s continued investment in the company’s growth.

For further insights into AU:EZZ stock, check out TipRanks’ Stock Analysis page.

Trending Articles

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.